Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest GroupEric Faulkner, Anke-Peggy Holtorf, Surrey Walton, et al.
British Journal of Clinical Pharmacology|July 29, 2026
MT-RNR1 genotype testing for preventing aminoglycoside-mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)John H McDermott, Sian Hilton, Cinzia Dello Russo, et al.
QJM : Monthly Journal of the Association of Physicians|October 17, 2024
Pre-emptive pharmacogenetic testing in the acute hospital setting: a cross-sectional studyJohn H McDermott, Kerry Burke, Neil Fullerton, et al.
Pharmacoeconomics|February 27, 2026
Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder GroupOlena Mandrik, Chloe Thomas, Alice Bessey, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 12, 2024
Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with non-psychotic mental health problems: a pragmatic randomized controlled trialMike Slade, Stefan Rennick-Egglestone, Rachel A Elliott, et al.
International Journal of Neonatal Screening|October 24, 2025
Methodological and Procedural Considerations for Developing Decision Analytic Models to Assess the Health Economic Impacts of Newborn Bloodspot Screening: A Systematic Methodological ReviewJim Chilcott, Alice Bessey, James R Bonham, et al.
Human Mutation|May 5, 2017
Critical points for an accurate human genome analysisStefan J White, Jeroen F J Laros, Egbert Bakker, et al.
British Journal of Clinical Pharmacology|July 2, 2026
UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)Dharmisha Chauhan, Cinzia Dello Russo, Jack Thompson, et al.
Pharmacogenomics|June 23, 2011
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET studyWilliam G Newman, Katherine Payne, Karen Tricker, et al.
BMC Cancer|June 20, 2020
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)David P French, Susan Astley, Adam R Brentnall, et al.
Pageof 19